136 related articles for article (PubMed ID: 22725270)
1. Expression of cancer stem cell markers ALDH1 and Bmi1 in oral erythroplakia and the risk of oral cancer.
Feng JQ; Xu ZY; Shi LJ; Wu L; Liu W; Zhou ZT
J Oral Pathol Med; 2013 Feb; 42(2):148-53. PubMed ID: 22725270
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of cancer stem cell markers ALDH1 and CD133 correlate with a high risk of malignant transformation of oral leukoplakia.
Liu W; Wu L; Shen XM; Shi LJ; Zhang CP; Xu LQ; Zhou ZT
Int J Cancer; 2013 Feb; 132(4):868-74. PubMed ID: 22782852
[TBL] [Abstract][Full Text] [Related]
3. Aldehyde dehydrogenase 1 expression correlated with malignant potential of oral lichen planus.
Xu Z; Shen Z; Shi L; Sun H; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Oct; 17(5):408-11. PubMed ID: 23707659
[TBL] [Abstract][Full Text] [Related]
4. Bmi1 expression in oral lichen planus and the risk of progression to oral squamous cell carcinoma.
Ma L; Wang H; Yao H; Zhu L; Liu W; Zhou Z
Ann Diagn Pathol; 2013 Aug; 17(4):327-30. PubMed ID: 23639414
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of ALDH1, Bmi1, and OCT4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma.
Rao RS; Raju K L; Augustine D; Patil S
Cancer Control; 2020; 27(1):1073274820904959. PubMed ID: 32951453
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cell markers ALDH1 and Bmi1 expression in oral erythroplakia revisited: Implication for driving the process of field cancerization.
Feng J; Zhou Z; Shi L; Yang X; Liu W
J Oral Pathol Med; 2020 Jan; 49(1):96-99. PubMed ID: 31444928
[TBL] [Abstract][Full Text] [Related]
7. Expression and associations of TRAF1, BMI-1, ALDH1, and Lin28B in oral squamous cell carcinoma.
Wu TF; Li YC; Ma SR; Bing-Liu ; Zhang WF; Sun ZJ
Tumour Biol; 2017 Apr; 39(4):1010428317695930. PubMed ID: 28381191
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells.
Lo WL; Yu CC; Chiou GY; Chen YW; Huang PI; Chien CS; Tseng LM; Chu PY; Lu KH; Chang KW; Kao SY; Chiou SH
J Pathol; 2011 Mar; 223(4):482-95. PubMed ID: 21294122
[TBL] [Abstract][Full Text] [Related]
9. Putative cancer stem cell marker expression in oral epithelial dysplasia and squamous cell carcinoma.
Abdulmajeed AA; Dalley AJ; Farah CS
J Oral Pathol Med; 2013 Nov; 42(10):755-60. PubMed ID: 23614644
[TBL] [Abstract][Full Text] [Related]
10. Expression of podoplanin and ABCG2 in oral erythroplakia correlate with oral cancer development.
Feng JQ; Mi JG; Wu L; Ma LW; Shi LJ; Yang X; Liu W; Zhang CP; Zhou ZT
Oral Oncol; 2012 Sep; 48(9):848-52. PubMed ID: 22525603
[TBL] [Abstract][Full Text] [Related]
11. Correlation of ALDH1, CD44, OCT4 and SOX2 in tongue squamous cell carcinoma and their association with disease progression and prognosis.
Huang CF; Xu XR; Wu TF; Sun ZJ; Zhang WF
J Oral Pathol Med; 2014 Aug; 43(7):492-8. PubMed ID: 24450601
[TBL] [Abstract][Full Text] [Related]
12. CD44 and ALDH1 immunoexpression as prognostic indicators of invasion and metastasis in oral squamous cell carcinoma.
Ortiz RC; Lopes NM; Amôr NG; Ponce JB; Schmerling CK; Lara VS; Moyses RA; Rodini CO
J Oral Pathol Med; 2018 Sep; 47(8):740-747. PubMed ID: 29791975
[TBL] [Abstract][Full Text] [Related]
13. Loss of CD44 and SOX2 expression is correlated with a poor prognosis in esophageal adenocarcinoma patients.
Honing J; Pavlov KV; Meijer C; Smit JK; Boersma-van Ek W; Karrenbeld A; Burgerhof JG; Kruyt FA; Plukker JT
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S657-64. PubMed ID: 24833101
[TBL] [Abstract][Full Text] [Related]
14. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M
J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751
[TBL] [Abstract][Full Text] [Related]
15. Cancer Stem Cell Markers, CD44 and ALDH1, for Assessment of Cancer Risk in OPMDs and Lymph Node Metastasis in Oral Squamous Cell Carcinoma.
Dhumal SN; Choudhari SK; Patankar S; Ghule SS; Jadhav YB; Masne S
Head Neck Pathol; 2022 Jun; 16(2):453-465. PubMed ID: 34655409
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell markers in prostate cancer: an immunohistochemical study of ALDH1, SOX2 and EZH2.
Matsika A; Srinivasan B; Day C; Mader SA; Kiernan DM; Broomfield A; Fu J; Hooper JD; Kench JG; Samaratunga H
Pathology; 2015 Dec; 47(7):622-8. PubMed ID: 26517640
[TBL] [Abstract][Full Text] [Related]
17. Aldehyde dehydrogenase isoform 1 (ALDH1) expression as a predictor of radiosensitivity in laryngeal cancer.
Martín M; Hinojar A; Cerezo L; García J; Lopez M; Prada J; Marín A; Gamallo C
Clin Transl Oncol; 2016 Aug; 18(8):825-30. PubMed ID: 26572760
[TBL] [Abstract][Full Text] [Related]
18. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors.
Lan J; Huang B; Liu R; Ju X; Zhou Y; Jiang J; Liang W; Shen Y; Li F; Pang L
Int J Clin Exp Pathol; 2015; 8(10):12621-33. PubMed ID: 26722452
[TBL] [Abstract][Full Text] [Related]
19. Aldehyde dehydrogenase 1, a functional marker for identifying cancer stem cells in human nasopharyngeal carcinoma.
Wu A; Luo W; Zhang Q; Yang Z; Zhang G; Li S; Yao K
Cancer Lett; 2013 Apr; 330(2):181-9. PubMed ID: 23220285
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological significance of cancer stem cell markers CD44 and ALDH1 expression in breast cancer.
Louhichi T; Ziadi S; Saad H; Dhiab MB; Mestiri S; Trimeche M
Breast Cancer; 2018 Nov; 25(6):698-705. PubMed ID: 29845398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
